Pechánová Olga, Zicha Josef, Kojsová Stanislava, Dobesová Zdenka, Jendeková Lýdia, Kunes Jaroslav
Institute of Normal and Pathological Physiology, Slovak Academy of Sciences, Sienkiewiczova 1, 813 71 Bratislava, Slovak Republic.
Clin Sci (Lond). 2006 Feb;110(2):235-42. doi: 10.1042/CS20050227.
The imbalance between NO (nitric oxide) and ROS (reactive oxygen species) is an important factor in the development of hypertension. The aim of the present study was to determine the preventive and therapeutic effects of NAC (N-acetylcysteine) in SHRs (spontaneously hypertensive rats). Young and adult SHRs and WKY (Wistar-Kyoto) rats were treated with NAC (20 g/l in the drinking water). After 8 weeks of treatment, BP (blood pressure) and NOS (NO synthase) activity, conjugated dienes and GSH (reduced glutathione) in the kidney and left ventricle were determined. Protein expression of eNOS (endothelial NOS), inducible NOS and NF-kappaB (nuclear factor kappaB) were also determined in the left ventricle and kidney. Chronic NAC treatment partially attenuated the rise in BP in young SHRs (179+/-6 compared with 210+/-8 mmHg in untreated animals), but it had no significant effect on BP in adult SHRs. The antioxidant action of NAC, measured as a decrease of the concentration of conjugated dienes or inhibition of NF-kappaB expression, was greater in young than in adult SHRs. Similarly, eNOS protein expression was attenuated more in young than in adult SHRs, although NAC treatment increased NOS activity to a similar extent in both young and adult rats. In conclusion, both decreased ROS production and increased NOS activity appear to participate in the BP changes after NAC treatment in young SHRs. In adult SHRs with established hypertension, however, the secondary alterations (such as pronounced structural remodelling of resistance vessels) might attenuate the therapeutic effect of NAC.
一氧化氮(NO)与活性氧(ROS)之间的失衡是高血压发生发展的一个重要因素。本研究的目的是确定N-乙酰半胱氨酸(NAC)对自发性高血压大鼠(SHRs)的预防和治疗作用。将年轻和成年的SHRs以及Wistar-Kyoto(WKY)大鼠用NAC(饮用水中浓度为20 g/l)进行处理。治疗8周后,测定血压(BP)、一氧化氮合酶(NOS)活性、肾脏和左心室中的共轭二烯以及还原型谷胱甘肽(GSH)。还测定了左心室和肾脏中内皮型一氧化氮合酶(eNOS)、诱导型一氧化氮合酶和核因子κB(NF-κB)的蛋白表达。慢性NAC治疗使年轻SHRs的血压升高部分减轻(与未治疗动物的210±8 mmHg相比为179±6 mmHg),但对成年SHRs的血压没有显著影响。以共轭二烯浓度降低或NF-κB表达抑制来衡量,NAC的抗氧化作用在年轻SHRs中比成年SHRs中更强。同样,eNOS蛋白表达在年轻SHRs中比成年SHRs中减弱得更多,尽管NAC治疗在年轻和成年大鼠中使NOS活性增加的程度相似。总之,ROS生成减少和NOS活性增加似乎都参与了NAC治疗后年轻SHRs的血压变化。然而,在已患高血压的成年SHRs中,继发性改变(如阻力血管明显的结构重塑)可能会减弱NAC的治疗效果。